Abstract:Background: The GABRA1 gene, encoding the GABR A R subunit α1, plays vital roles in inhibitory neurons. Previously, the GABRA1 gene has been identified to be associated with developmental and epileptic encephalopathy (DEE) and idiopathic generalized epilepsy (IGE). This study aims to explore the phenotypic spectrum of GABRA1 and molecular subregional effect analysis. Methods: Trios-based whole-exome sequencing was performed in patients with epilepsy. Previously reported GABRA1 mutations were systematically reviewed to analyze the molecular subregional effects. Results: De novo GABRA1 mutations were identified in six unrelated patients with heterogeneous epilepsy, including three missense mutations (p.His83Asn, p.Val207Phe, and p.Arg214Cys) and one frameshift mutation (p.Thr453Hisfs*47). The two missense mutations, p.His83Asn and p.Val207Phe, were predicted to decrease the protein stability but no hydrogen bond alteration, with which the two patients also presented with mild genetic epilepsy with febrile seizures plus and achieved seizure-free status by monotherapy. The missense variant p.Arg214Cys was predicted to decrease protein stability and destroy hydrogen bonds with surrounding residues, which was recurrently identified in three cases with severe DEE. The frameshift variant p.Thr453Hisfs*47 was located in the last fifth residue of the C-terminus and caused an extension of 47 amino acids, with which the patients presented with moderated epilepsy with generalized tonic-clonic seizures alone (GTCA) but achieved seizure-free status by four drugs. The four variants were not presented in gnomAD and were evaluated as "pathogenic/likely pathogenic" according to ACMG criteria. Analysis of all reported cases indicated that patients with mutations in the N-terminal extracellular region presented a significantly higher percentage of FS and DEE, and the patients with variants in the transmembrane region presented earlier seizure onset ages. Significance: This study suggested that GABRA1 variants were potentially associated with a spectrum of epilepsies, including EFS+, DEE, and GTCA. Phenotypic severity may be associated with the damaging effect of variants. The molecular subregional effects help in understanding the underlying mechanism of phenotypic variation.

Clinical whole-exome sequencing reveals a novel missense pathogenic variant of GNAO1 in a patient with infantile-onset epilepsy.

Variable epilepsy phenotypes associated with heterozygous mutation in the SCN9A gene: report of two cases

Phenotypes of GNAO1 Variants in a Chinese Cohort

SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures

[Genetic analysis of a case of mild epilepsy due to variant of SCN9A gene]

A Heterozygous Pathogenic Variant in the ATP6V1A Gene Triggering Epilepsy in a Large Chinese Pedigree.

De novo GABRA1 variants in childhood epilepsies and the molecular subregional effects

Clinical Features and Gene Mutations Analysis in 62 Children with Early - Onset Epileptic Encephalopathy of Un-Known Causes

Exome Sequencing of 963 Chinese Families Identifies Novel Epilepsy Candidate Genes

Novel Mutations and Phenotypes of Epilepsy-Associated Genes in Epileptic Encephalopathies.

Exome sequencing identifies molecular diagnosis in children with drug-resistant epilepsy

Gene Mutational Analysis in a Cohort of Chinese Children with Unexplained Epilepsy: Identification of a New KCND3 Phenotype and Novel Genes Causing Dravet Syndrome

Altered Inhibitory Synapses in De Novo GABRA5 and GABRA1 Mutations Associated with Early Onset Epileptic Encephalopathies.

Novel variants of SYNGAP1 associated epileptic encephalopathy: two cases report and literature review

Gene mutation analysis of 175 Chinese patients with early‐onset epileptic encephalopathy

Functional analysis of a novel nonsense PPP1R12A variant in a Chinese family with infantile epilepsy

A Heterozygous Missense Variant in the YWHAG Gene Causing Developmental and Epileptic Encephalopathy 56 in a Chinese Family.

Next Generation Sequencing in Children with Unexplained Epilepsy: A Retrospective Cohort Study.

Case report: Novel NUS1 variant in a Chinese patient with tremors and intellectual disability

An intractable epilepsy phenotype of ASNS novel mutation in two patients with asparagine synthase deficiency

De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy